References
- Cunningham FG. Treatment and prevention of female pelvic infection. The quest for single agent therapy. Am J Obstet Gynecol 1987; 157: 485–488.
- Mandell GL. In vitro microbiology and pharmacokinetics of piperacillin. Clin Ther 1985; 7 (suppl B): 28–35.
- Takase Z. Transfer of piperacillin to various uterine tissues. Piperacillin study group for application in the field of obstetrics and gynecology. Biol Res Pregnancy 1984; 5: 48–56.
- Bach VT, Thadepalli H. Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents. Chemotherapy 1980; 26: 344–353.
- McAllister TA. Piperacillin against clinical isolates: antimicrobial profile and clinical role. J Antimicrob Chemother 1982; 9 (suppl B): 75–84.
- Faro S, Pastorek JG, Aldridge KE, Martens M, Phillips LE, Nicaud S, Cunningham G. Piperacillin versus clindamycin plus gentamicin in the treatment of postpartum endometritis. Curr Ther Res 1987; 42: 995–1002.
- Gilstrap LC, Maier RC, Gibbs RS, Connor KD, St Clair PJ. Piperacillin versus clindamycin plus gentamicin for pelvic infections. Obstet Gynecol 1984; 64: 762–766.
- Gunning JE. A comparison of piperacillin and clindamycin plus gentamicin in women with pelvic infections. Surg Gynecol Obstet 1986; 163: 156–162.
- Hemsell DL, Hemsell PG, Heard MC, Nobles BJ. Piperacillin and a combination of clindamycin and gentamicin for the treatment of hospital and community acquired pelvic infections including pelvic abscess. Surg Gynecol Obstet 1987; 165: 223–229.